These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30039405)

  • 21. Current advances in drug discovery for Chagas disease.
    Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
    Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins.
    Robledo-O'Ryan N; Matos MJ; Vazquez-Rodriguez S; Santana L; Uriarte E; Moncada-Basualto M; Mura F; Lapier M; Maya JD; Olea-Azar C
    Bioorg Med Chem; 2017 Jan; 25(2):621-632. PubMed ID: 27908757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diterpenoid alkaloid derivatives as potential chemotherapeutic agents in American trypanosomiasis.
    González P; Marín C; Rodríguez-González I; Illana A; Mateo H; Longoni SS; Rosales MJ; González-Coloma A; Reina M; Sánchez-Moreno M
    Pharmacology; 2006; 76(3):123-8. PubMed ID: 16391494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruzi.
    Keenan M; Alexander PW; Chaplin JH; Abbott MJ; Diao H; Wang Z; Best WM; Perez CJ; Cornwall SM; Keatley SK; Thompson RC; Charman SA; White KL; Ryan E; Chen G; Ioset JR; von Geldern TW; Chatelain E
    Future Med Chem; 2013 Oct; 5(15):1733-52. PubMed ID: 24144410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
    Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
    Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
    Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
    Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids.
    Reviriego F; Olmo F; Navarro P; Marín C; Ramírez-Macías I; García-España E; Albelda MT; Gutiérrez-Sánchez R; Sánchez-Moreno M; Arán VJ
    Parasitology; 2017 Aug; 144(9):1133-1143. PubMed ID: 28367781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indazoles: a new top seed structure in the search of efficient drugs against Trypanosoma cruzi.
    Aguilera-Venegas B; Olea-Azar C; Arán VJ; Speisky H
    Future Med Chem; 2013 Oct; 5(15):1843-59. PubMed ID: 24144415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
    Maluf FV; Andricopulo AD; Oliva G; Guido RV
    Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide).
    Moreno ÉM; Leal SM; Stashenko EE; García LT
    BMC Complement Altern Med; 2018 Jul; 18(1):225. PubMed ID: 30053848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Approaches to Drug Discovery for Chagas Disease: Methodological Advances.
    Scarim CB; Chin CM
    Comb Chem High Throughput Screen; 2019; 22(8):509-520. PubMed ID: 31608837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
    Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
    Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico tools to study molecular targets of neglected diseases: inhibition of TcSir2rp3, an epigenetic enzyme of Trypanosoma cruzi.
    López-López E; Barrientos-Salcedo C; Prieto-Martínez FD; Medina-Franco JL
    Adv Protein Chem Struct Biol; 2020; 122():203-229. PubMed ID: 32951812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chagas disease drug discovery: toward a new era.
    Chatelain E
    J Biomol Screen; 2015 Jan; 20(1):22-35. PubMed ID: 25245987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 2-arylazoimidazole derivatives as inhibitors of Trypanosoma cruzi proliferation: Synthesis and evaluation of their biological activity.
    Salerno A; Celentano AM; López J; Lara V; Gaozza C; Balcazar DE; Carrillo C; Frank FM; Blanco MM
    Eur J Med Chem; 2017 Jan; 125():327-334. PubMed ID: 27688187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo identification of tetradentated polyamine complexes as highly efficient metallodrugs against Trypanosoma cruzi.
    Olmo F; Cussó O; Marín C; Rosales MJ; Urbanová K; Krauth-Siegel RL; Costas M; Ribas X; Sánchez-Moreno M
    Exp Parasitol; 2016 May; 164():20-30. PubMed ID: 26874306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infectious diseases. Drug developers finally take aim at a neglected disease.
    Leslie M
    Science; 2011 Aug; 333(6045):933-5. PubMed ID: 21852468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.